Skip to main content
. 2008 Sep 1;31(9):1229–1237.

Table 1.

Comparison Between the Sleep Scoring Parameters Found Before (1st Night = Baseline) and After (2nd Night) Treatment with Pramipexole or placebo

Baseline
Treatment
ANOVA
Post-hoc comparisons
Pramipexole
Placebo
Pramipexole
Placebo
Baseline vs. Treatment
Pramipexole vs. Placebo
Mean SD Mean SD Mean SD Mean SD Night Group Night×Group Pramipexole Placebo Baseline Treatment
TIB, min 504.2 96.16 514.5 83.99 518.4 43.40 481.2 91.21 N.S. N.S. N.S.
SPT, min 466.7 98.82 480.3 82.86 490.7 48.43 453.4 88.63 N.S. N.S. N.S.
TST, min 332.4 118.99 397.3 92.01 407.4 62.14 365.8 79.39 N.S. N.S. 0.009
SL, min 26.0 30.76 21.9 22.38 17.6 22.64 17.5 20.62 N.S. N.S. N.S.
RL, min 117.2 89.95 96.8 39.26 133.8 88.29 120.6 63.38 N.S. N.S. N.S.
SS/hour 11.2 4.58 12.6 4.10 13.4 4.28 12.2 4.09 N.S. N.S. N.S.
AWN/hour 4.9 2.68 4.3 2.55 5.7 3.26 4.2 2.38 N.S. N.S. N.S.
SE% 65.2 19.36 77.1 11.10 78.7 10.41 76.6 11.53 0.035 N.S. 0.025 0.0008 N.S.
WASO, % 30.0 18.84 17.3 12.38 17.0 9.05 18.6 12.27 0.1>P>0.05 N.S. 0.02
S1, % 6.3 6.02 6.7 4.04 5.3 4.74 5.9 4.57 N.S. N.S.
S2, % 38.0 10.79 43.6 10.65 49.9 12.00 44.7 10.32 0.008 N.S. 0.03 0.0002 N.S.
SWS, % 13.7 8.32 15.3 8.92 15.6 7.50 16.2 5.94 N.S. N.S. N.S.
REM, % 12.1 7.91 17.1 5.23 12.2 4.82 14.6 4.54 N.S. 0.005 N.S. 0.007 N.S.

TIB, time in bed; SPT, sleep period time; TST, total sleep time; SL, sleep latency; RL, REM latency; SS, stage shifts; AWN, awakenings number; SE, sleep efficiency; WASO, wakefulness after sleep onset; S1, stage 1; S2, stage 2; SWS, slow wave sleep; REM, REM sleep.